Physician profile
Christopher Bolich
NPI 1861592347
$582.71
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.70 · 2023: $345 · 2024: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $546.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $65.82 | 2023-2024 | Enhertu, Calquence |
| Foundation Medicine, INC. | $60.06 | 2023 | Foundationone Cdx, Foundationone Liquid Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $52.21 | 2023 | |
| Pharmacosmos Therapeutics INC. | $37.98 | 2023 | Monoferric |
| Takeda Pharmaceuticals U.S.A., INC. | $34.96 | 2023-2024 | Fruzaqla, Hyqvia |
| Novartis Pharmaceuticals Corporation | $31.35 | 2023-2024 | |
| Seagen INC. | $29.98 | 2023 | Padcev, Adcetris |
| Tempus Ai, INC | $27.78 | 2024 | Xt Cdx |
| Genmab U.S., INC. | $27.31 | 2023-2024 | Tivdak |
| Abbott Laboratories | $20.29 | 2022 | |
| Philips North America LLC | $19.75 | 2023 | |
| Adc Therapeutics America, INC. | $18.64 | 2023 | |
| Eisai INC. | $17.94 | 2023 | |
| Progenics Pharmaceuticals, INC. | $16.87 | 2023 | Pylarify |
| Janssen Biotech, INC. | $16.84 | 2024 | Darzalex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $16.58 | 2024 | |
| Novocure INC. | $16.41 | 2024 | Optune |
| Ge Healthcare | $16.41 | 2022 | |
| Stemline Therapeutics INC. | $15.13 | 2024 | Orserdu |
| Morphosys, US INC. | $13.82 | 2023 | Monjuvi |
| Sobi, INC | $13.38 | 2024 | |
| Incyte Corporation | $13.20 | 2023 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bolich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.